Baxter Canada invests over $26M in Alliston facility for IV and dialysis solutions

Baxter Canada announced a total investment of over $26 million in its Alliston, Ontario facility, including $7.5 million in 2018 and an additional $19 million over the next two years, to maintain regulatory compliance and prepare for FDA registration.

“The Alliston facility is truly best in class, from our management system with continuous improvement at its core, to a culture of quality and safety.”baxter.ca

• 1 source
• baxter.caBAXTER CANADA INVESTS OVER $26 MILLION IN ALLISTON FACILITY PRODUCING LIFE-SUSTAINING INTRAVENOUS AND DIALYSIS SOLUTIONS | BaxterDec 13, 2018

Summarized from public sources; check the original articles before acting on it.